Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Hypersensitivity × tislelizumab × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 3 Carcinoma, Hepatocellular 3 Rectal Neoplasms 2 Triple Negative Breast Neoplasms 1 Liver Diseases 1 Hypersensitivity 1 Biliary Tract Neoplasms 1 Advanced Colorectal Carcinoma 1

Interventions

Ultrasonography 2 tislelizumab 1 Mammography 1 Lenalidomide 1 Immune Checkpoint Inhibitors 1 High-Energy Shock Waves 1 Cetirizine 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06448169 2024-06-07

Observational Study on the Sensitivity of Neoadjuvant Immunotherapy in Early Triple-Negative Breast Cancer

Shandong University

Not yet recruiting

Hypersensitivity, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡